Skip to main content
Skip to main content
Back to Grand Rounds
Grand RoundsWeekly Evidence Brief

Transplant Surgery

Edition

30-Second Takeaway

  • Normothermic regional perfusion substantially improves outcomes in DCD kidney transplantation, especially in higher-risk donors and recipients.
  • In PSC liver transplantation, Roux-en-Y biliary reconstruction improves patient and graft survival compared with duct-to-duct.
  • Early MACE after liver transplantation are uncommon but strongly predict poorer long-term survival.
  • Emerging tools and techniques may refine post-transplant surveillance and reduce surgical morbidity.
  • Obesity pharmacotherapy, particularly GLP-1–based agents, is promising but understudied in kidney and liver transplant recipients.

Week ending January 24, 2026

Sharpening perioperative and long‑term decision-making in solid organ transplantation

Normothermic regional perfusion improves outcomes in US DCD kidney transplantation

ANNALS OF SURGERYJan 21, 2026

In 21,010 adult DCD kidney transplants, normothermic regional perfusion (NRP) markedly reduced delayed graft function versus non-NRP (30.3% vs 49.7%). NRP was associated with shorter post-transplant length of stay (median 4 vs 5 days). Overall graft and patient survival, including three-year outcomes, were significantly better with NRP. Short versus long NRP durations showed no difference in overall graft survival. NRP benefits were greatest in elderly donors or recipients, high donor BMI, higher KDPI, and prolonged pretransplant dialysis.

Roux-en-Y biliary reconstruction improves survival in PSC liver transplantation

TRANSPLANTATIONJan 23, 2026

This meta-analysis pooled 12 studies with 1418 PSC liver transplant recipients comparing duct-to-duct (DD) and Roux-en-Y (RY) reconstruction. Rates of biliary strictures and leaks did not differ significantly between DD and RY. DD reconstruction lowered cholangitis risk, but RY conferred superior patient survival (HR 0.69 favoring RY). Graft survival was also better with RY (HR 1.38 indicating higher failure risk with DD). Other outcomes, including cholangiocarcinoma, recurrent PSC, hepatic artery thrombosis, and retransplantation, were similar. RY may represent the safer default reconstruction strategy in PSC despite more cholangitis.

Early MACE after liver transplantation are uncommon but prognostically important

ECLINICALMEDICINEJan 19, 2026

Among 10,213 English liver transplants, first-year major adverse cardiovascular events (MACE) occurred in 2.6% of recipients. MACE-related mortality within one year was very low at 0.1%, largely due to nonfatal events. Stroke was the most frequent MACE, followed by myocardial infarction. First-year MACE independently predicted worse long-term all-cause mortality (HR 1.37). Risk of MACE increased with older age, male sex, diabetes, and higher Charlson comorbidity scores.

Sex disparities persist across the transplant continuum

TRANSPLANTATIONJan 23, 2026

This review synthesizes evidence on sex differences in kidney, heart, liver, and lung transplantation. Women, especially older women, have reduced access to referral, waitlisting, activation, and transplantation compared with men. Sex differences in graft loss and mortality vary by donor sex and recipient age, reflecting biologic and selection effects. Provider bias, access to bridge therapies, and gendered health behaviors may contribute to observed disparities. The authors call for mechanistic research and explicit equity efforts within transplant programs to address sex disparities.

References

Numbered in order of appearance. Click any reference to view details.

Additional Reads

Optional additional studies from this edition.

Edition context

Clinical signal

  • Donor and intraoperative management strategies can meaningfully alter DCD kidney transplant outcomes in current observational data.
  • Choice of biliary reconstruction for PSC has survival implications beyond immediate biliary complications.
  • Cardiometabolic, infectious, microbiome, and sex-related factors shape long-term outcomes and access in solid organ transplantation.